Drug price disruptor EQRx hits the big leagues with $ 1.8 billion PSPC deal and new CEO at the helm – Endpoints News



[ad_1]

Tadataka Yamada, an imposing physician-researcher who made a name for himself in academia before transforming drug development at GlaxoSmithKline and developing vaccines for malaria and meningitis at the Gates Foundation, has died suddenly of natural causes at his Seattle home on Wednesday morning.

He was 76 years old. David Socks of Frazier Healthcare Partners has confirmed his death.

Widely known by the mononym “Tachi”, Yamada had a career as a globetrotter and entered the industry relatively late in his life. A 2004 Independent The article noted that GSK asked Yamada to stay past his 60th birthday, the company’s usual retirement age. Yamada would continue to work for the next 17 years, leading the Global Health division of the Gates Foundation for 6 years, funding Jim Wilson’s gene therapy work when few touched it, launching Takeda Vaccines and co-founding a premier biotechnology series. plan.

[ad_2]

Source link